deltibant
Also Known As:
CP 0127; CP-0127
Networked: 7
relevant articles (0 outcomes,
3 trials/studies)
Bio-Agent Context: Research Results
Experts
Related Diseases
1. | Sepsis (Septicemia)
02/12/1997
- " Deltibant may have some effect on survival in patients with SIRS and gram-negative sepsis; however, additional studies would be required to prove this." 02/12/1997
- " CP-0127 SIRS and Sepsis Study Group." 02/12/1997
- " To test the effect of a novel bradykinin antagonist, deltibant (CP-0127), on survival, organ dysfunction, and other outcomes in patients with the systemic inflammatory response syndrome (SIRS) and presumed sepsis. " 02/12/1997
- " Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127). " 01/01/2002
- " Only three peptide type B2 antagonists, NPC 567, CP-0127 and HOE-140, have been evaluated in clinical studies so far, and some beneficial effects of B2 antagonists have been shown for rhinitis, asthma, systemic inflammatory response syndrome/sepsis and brain injury. "
|
2. | Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
02/12/1997
- " To test the effect of a novel bradykinin antagonist, deltibant (CP-0127), on survival, organ dysfunction, and other outcomes in patients with the systemic inflammatory response syndrome (SIRS) and presumed sepsis. " 02/12/1997
- " Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127). " 01/01/2002
- " Only three peptide type B2 antagonists, NPC 567, CP-0127 and HOE-140, have been evaluated in clinical studies so far, and some beneficial effects of B2 antagonists have been shown for rhinitis, asthma, systemic inflammatory response syndrome/sepsis and brain injury. "
|
3. | Rhinitis
|
4. | Brain Injuries (Brain Injury)
|
5. | Brain Edema (Cerebral Edema)
|
|
Related Drugs and Biologics
Related Therapies and Procedures